Evidence map›Paper›PMID 35651368›Full record

ArticleERJ open research2022

Prevalence, time trends and treatment practices of asthma in India: the Global Asthma Network study.

Sheetu Singh, Sundeep Salvi, Daya Krishan Mangal, Meenu Singh, Shally Awasthi, Padukudru Anand Mahesh, Sushil K Kabra, Sabir Mohammed, Thevaruparambil U Sukumaran, Aloke G Ghoshal and 12 more

Open access · goldAbstract read
In one paragraph

Article in ERJ open research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Dupilumab Efficacy and Safety in Patients With Persistent Asthma: Asia-Pacific Region.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2025
    Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Characterization and cluster analysis of Indian adults with asthma in the Vellore district.The journal of allergy and clinical immunology. Global · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 11 institutions in 1 country.

Sheetu SinghDept of Pulmonary Medicine, Rajasthan Hospital, Jaipur, India.
Sundeep SalviPulmocare Research and Education Foundation, Pune, India.
Daya Krishan MangalDept of Public Health, IIHMR University, Jaipur, India.
Meenu SinghDept of Pediatrics, Postgraduate Institute of Medical Education and Research, Changdigarh, India.
Shally AwasthiDept of Pediatrics, King George's Medical University, Lucknow, India.
Padukudru Anand MaheshDept of Respiratory Medicine, Jagadguru Sri Shivarathreeshwara Medical College, JSSAHER, Mysuru, India.ORCID https://orcid.org/0000-0003-1632-5945
Sushil K KabraDept of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Sabir MohammedDept of Pulmonary Medicine, Kothari Medical College and Research Institute, Bikaner, India.
Thevaruparambil U SukumaranDept of Pediatrics, Caritas Hospital, Thellakom, Kottayam, India.
Aloke G GhoshalNational Allergy Asthma Bronchitis Institute, Kolkata, India.
Monica BarnePulmocare Research and Education Foundation, Pune, India.
Sanjeev SinhaDept of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Sanjay K KocharDept of Pulmonary Medicine, Kothari Medical College and Research Institute, Bikaner, India.
Nishtha SinghDept of Respiratory Medicine, Asthma Bhawan, Jaipur, India.
Udaiveer SinghDivision of Research, Asthma Bhawan, Jaipur, India.
Kamalesh Kumar PatelDept of Public Health, IIHMR University, Jaipur, India.
Arvind Kumar SharmaDept of Community Medicine, Mahatma Gandhi Medical College and Hospital, Jaipur, India.
Bhushan GiraseFamily Health, PATH, New Delhi, India.
Anil ChauhanDept of Telemedicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Niranjan SitNational Allergy Asthma Bronchitis Institute, Kolkata, India.
Jayaraj B SiddaiahDept of Respiratory Medicine, Jagadguru Sri Shivarathreeshwara Medical College, JSSAHER, Mysuru, India.
Virendra SinghDept of Respiratory Medicine, Asthma Bhawan, Jaipur, India.
All India Institute of Medical Sciences · INIIHMR University · INJSS Academy of Higher Education and Research · INNational Allergy Asthma Bronchitis Institute · INPost Graduate Institute of Medical Education and Research · INSardar Patel Medical College · INCaritas Hospital · INGandhi Medical College & Hospital · INKing George's Medical University · INProgram for Appropriate Technology in Health · INRajasthan Dental College and Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The objective of this subanalysis of data from centres across urban areas in India of the Global Asthma Network (GAN) was to study 1) the prevalence of symptoms of asthma in children and adults, 2) the change in prevalence of asthma and its trigger factors since the International Study of Asthma and Allergies in Childhood (ISAAC), and 3) current asthma treatment practice. Methods: In this cross-sectional, multicentre, school-based and self-administered questionnaire, responses from children aged 6-7 years and 13-14 years, and their respective parents, were analysed. Results: The GAN Phase I study included 20 084 children in the 6-7-year age group, 25 887 children in the 13-14-year age group and 81 296 parents. The prevalence of wheeze in the previous 12 months was 3.16%, 3.63% and 3.30% in the three groups, respectively. In comparison to the ISAAC studies, there was a significant reduction in the prevalence of current wheeze (p<0.001). Bivariate analysis revealed a significant reduction in the prevalence of trigger factors. Almost 82% of current wheezers and 70% of subjects with symptoms of severe asthma were not clinically diagnosed as having asthma. The daily use of inhaled corticosteroids (ICS) was less than 2.5% in subjects with current wheeze and those with symptoms of severe asthma but less than 1% used daily ICS when asthma remained undiagnosed. Conclusion: The prevalence of current wheeze and its causal factors showed a significant reduction compared to previous ISAAC studies. Among subjects with current wheeze and symptoms of severe asthma, the problem of under-diagnosis and under-treatment was widespread.

Identifiers

PMID35651368
PMCPMC9149387
OpenAlexW4211022032

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.